Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2003
Do dose-volume metrics predict pulmonary function changes in lung irradiation?
A M Allen, G T Henning, R K Ten Haken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2000
Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma
G T Henning, S E Schild, S L Stafford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 4, 2000
Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma
G T Henning, S E Schild, S L Stafford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 2010
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)
A Jatoi, S E Schild, N Foster, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2003
Do dose-volume metrics predict pulmonary function changes in lung irradiation?
A M Allen, G T Henning, R K Ten Haken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2000
Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma
G T Henning, S E Schild, S L Stafford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 4, 2000
Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma
G T Henning, S E Schild, S L Stafford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 2010
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)
A Jatoi, S E Schild, N Foster, et al.
Page
of 1